Eudaimonia Partners’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$346K Buy
3,677
+24
+0.7% +$2.11K 0.08% 185
2023
Q4
$341K Sell
3,653
-285
-7% -$22.8K 0.09% 173
2023
Q3
$322K Buy
3,938
+18
+0.5% +$1.56K 0.08% 224
2023
Q2
$335K Sell
3,920
-476
-11% -$40.7K 0.08% 238
2023
Q1
$386K Buy
4,396
+1
+0% +$93 0.09% 219
2022
Q4
$374K Buy
4,395
+3
+0.1% +$256 0.09% 216
2022
Q3
$347K Sell
4,392
-6,402
-59% -$540K 0.09% 212
2022
Q2
$821K Buy
10,794
+1,811
+20% +$148K 0.15% 155
2022
Q1
$785K Buy
+8,983
New +$867K 0.13% 181
2021
Q3
$799K Buy
8,208
+33
+0.4% +$3.27K 0.14% 171
2021
Q2
$750K Buy
8,175
+3,006
+58% +$258K 0.14% 172
2021
Q1
$402K Buy
5,169
+683
+15% +$52.3K 0.08% 229
2020
Q4
$307K Buy
4,486
+2
+0% +$115 0.07% 252
2020
Q3
$217K Buy
4,484
+366
+9% +$18.4K 0.06% 273
2020
Q2
$199K Buy
4,118
+92
+2% +$3.86K 0.08% 236
2020
Q1
$137K Hold
4,026
0.06% 267
2019
Q4
$206K Buy
+4,026
New +$191K 0.08% 231

Other funds holding MS

Eudaimonia Partners's MS Position: Q1 2024 in Review

Eudaimonia Partners increased its Morgan Stanley (MS) stake by 0.66% in Q1 2024, buying an estimated $2.11K and bringing the position to 3,677 shares worth $346K. The position accounts for 0.08% of the portfolio, ranked #185.

Eudaimonia Partners first reported a position in MS in Q4 2019 and has held it in 17 quarters since. The position peaked at $821K in Q2 2022. 1,793 funds tracked by Wall St. Rank hold MS as of Q1 2024.

  • Eudaimonia Partners held 3,677 shares of Morgan Stanley worth $346K as of Q1 2024.
  • Eudaimonia Partners bought 24 Morgan Stanley shares in Q1 2024, an estimated $2.11K.
  • Morgan Stanley made up 0.08% of Eudaimonia Partners's portfolio in Q1 2024, its #185 holding.
  • Eudaimonia Partners first reported a position in Morgan Stanley in Q4 2019 and has held it in 17 quarters since.
  • Eudaimonia Partners's Morgan Stanley position peaked at $821K in Q2 2022.
  • 1,793 funds tracked by Wall St. Rank held Morgan Stanley as of Q1 2024.

Based on Eudaimonia Partners's 13F filing for Q1 2024, filed 25 Apr 2024.